Additionally, our study found that the expression of ASRGL1 and EREG can influence the sensitivity of colon cancer to certain antitumor drugs, and the specific mechanisms underlying these effects warrant further exploration. This evidence concerns the gene ASRGL1 and malignant colon neoplasm.